Five Star Equities Issues New Research Reports on FLEX, KBIO, NSR and SYMC


Follow this company

Companies Mentioned

NASDAQ:FLEX / NASDAQ:KBIO / NASDAQ:NSR / CNSX:SYMC
02/05/2014 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Flextronics International Ltd. (NASDAQ: FLEX) shares gained 0.37 percent to close at $8.14 a share last Tuesday. The stock traded between $8.06 and $8.20 on volume 4.72 million shares traded. Last week, the company reported GAAP earnings per share of $0.23 for the third quarter of fiscal 2013, an increase of 21.0 percent when compared to the previous quarter. Shares of Flextronics International are up approximately 5.0 percent year-to-date.

Get more information on Flextronics International and free access to the in-depth equity report at:  
www.FiveStarEquities.com/FLEX

KaloBios Pharmaceuticals Inc. (NASDAQ: KBIO) shares declined 10.0 percent to close at $2.61 a share Tuesday. The stock traded between $2.60 and $2.88 on volume of 2.84 million shares traded. The company fell sharply last Thursday after announcing it was discontinuing the clinical development of KB003 in severe asthma. Shares of KaloBios Pharmaceuticals are down approximately 40.0 percent year-to-date.

Get more information on KaloBios Pharmaceuticals and free access to the in-depth equity report at:  
www.FiveStarEquities.com/KBIO

Neustar Inc. (NYSE: NSR) shares increased 1.99 percent to close at $34.27 a share Tuesday. The stock traded between $33.70 and $34.37 on volume of 1.87 million shares traded. Shares were sent falling last Tuesday on growing concerns that the company may lose its contract with North American Portability Management LLC. Shares of Neustar are down approximately 30.0 percent year-to-date.

Get more information on Neustar and free access to the in-depth equity report at:  
www.FiveStarEquities.com/NSR

Symantec Corporation (NASDAQ: SYMC) shares declined 1.61 percent to close at $20.42 a share Tuesday. The stock traded between $20.39 and $20.98 on volume 12.52 million shares traded. The company reported revenue of $1.7 billion for the third quarter of fiscal 2014, a decrease of 5.0 percent year-over-year. Shares of Symantec have are down approximately 12.0 percent year-to-date.

Get more information on Symantec free access to the in-depth equity report at:  
www.FiveStarEquities.com/SYMC

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:          
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *